Inman D M, Horner P J
Department of Neurosurgery, University of Washington, Seattle, Washington 98104, USA.
Glia. 2007 Jul;55(9):942-53. doi: 10.1002/glia.20516.
In many CNS diseases, proliferation becomes dysregulated; cells divide and participate in pathological processes. Gliosis is a fundamental CNS response to trauma or disease in which cell hypertrophy and proliferation play prominent roles. The DBA/2J mouse is a glaucoma model in which mice experience gliosis concomitant with raised intraocular pressure that leads to a slow and progressive retinal ganglion cell axonopathy. We sought to determine if glaucomatous changes in DBA/2 retina would alter the regulation of cell proliferation, specifically in relation to retinal glia. Astrocyte and Müller glia populations within DBA/2 retina upregulated glial fibrillary acidic protein mRNA and protein compared with C57Bl/6; microglial cell number increased twofold from 4 to 10 months. Various bromodeoxyuridine (BrdU) injection paradigms were used to label dividing cells in DBA/2 and C57Bl/6 retina at 4 and 10 months of age. Very modest cell division in the retina, primarily in ganglion cell and inner nuclear layers, was observed at all ages. Immunohistochemistry indicated cell turnover primarily of NG2+ pericytes and Iba1+ microglia; astrocytes and Müller glia did not proliferate. There were no significant differences in BrdU+ cell numbers in 4 and 10-month-old retina, though 4-month retina had generally fewer BrdU+ cells than 10-month. C57Bl/6 retinas had fewer BrdU+ cells than DBA/2 retinas at all ages. These data show that, in contrast to gliosis in other CNS trauma and neurodegenerative diseases, glaucomatous changes in retina do not include substantive cell proliferation. Retinal changes in a chronic model of glaucoma engender a reactive, not proliferative, gliosis response.
在许多中枢神经系统疾病中,细胞增殖失调;细胞开始分裂并参与病理过程。胶质增生是中枢神经系统对创伤或疾病的一种基本反应,其中细胞肥大和增殖起着重要作用。DBA/2J小鼠是一种青光眼模型,在该模型中,小鼠会出现胶质增生,并伴有眼压升高,进而导致缓慢且进行性的视网膜神经节细胞轴突病变。我们试图确定DBA/2视网膜的青光眼性变化是否会改变细胞增殖的调节,特别是与视网膜神经胶质细胞相关的调节。与C57Bl/6相比,DBA/2视网膜中的星形胶质细胞和Müller胶质细胞群体上调了胶质纤维酸性蛋白的mRNA和蛋白质;小胶质细胞数量在4至10个月内增加了两倍。使用各种溴脱氧尿苷(BrdU)注射方案来标记4个月和10个月大的DBA/2和C57Bl/6视网膜中的分裂细胞。在所有年龄段都观察到视网膜中非常适度的细胞分裂,主要发生在神经节细胞层和内核层。免疫组织化学表明细胞更替主要发生在NG2+周细胞和Iba1+小胶质细胞中;星形胶质细胞和Müller胶质细胞不增殖。4个月和10个月大的视网膜中BrdU+细胞数量没有显著差异,不过4个月大的视网膜中BrdU+细胞通常比10个月大的少。在所有年龄段,C57Bl/6视网膜中的BrdU+细胞都比DBA/2视网膜中的少。这些数据表明,与其他中枢神经系统创伤和神经退行性疾病中的胶质增生不同,视网膜的青光眼性变化不包括实质性的细胞增殖。青光眼慢性模型中的视网膜变化引发的是一种反应性而非增殖性的胶质增生反应。